• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用超声衍生脂肪分数评估代谢功能障碍相关脂肪性肝病患儿的肝脂肪变性:首次大规模临床评估

Assessment of hepatic steatosis in children with metabolic dysfunction-associated steatotic liver disease using ultrasound derived fat fraction: first large-scale clinical evaluation.

作者信息

Liu Qin, Lyu Xiaohong, Ren Hongyan, Wang Mingxue, Liu Yumeng, Tang Rui, Liu Junting

机构信息

Department of Ultrasound, Children's Hospital of Capital Institute of Pediatrics, Beijing, China.

Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.

出版信息

Quant Imaging Med Surg. 2025 Jun 6;15(6):5582-5592. doi: 10.21037/qims-24-2393. Epub 2025 May 30.

DOI:10.21037/qims-24-2393
PMID:40606360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12209668/
Abstract

BACKGROUND

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health concern among children and adolescents. This study aims to evaluate the diagnostic value of ultrasound derived fat fraction (uDFF) in quantifying liver fat in children with MASLD and to explore the correlation between uDFF values and various anthropometric and biochemical parameters.

METHODS

This cross-sectional study included 230 children diagnosed with steatotic liver via ultrasound and 38 healthy controls. Physical examinations, laboratory tests, and abdominal ultrasound examination were conducted.

RESULTS

The study included 168 boys and 62 girls in MASLD group, with an average age of 9.8 years. Significant differences were observed in waist circumference, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) levels between boys and girls. Among the 230 children with MASLD, 191 in the Grade 1 MASLD group came with a mean uDFF value of 11.52% and 39 in the Grade 2 MASLD group came with a mean uDFF value of 19.10%, and there was a significant difference in the uDFF values when comparing between the two groups (P<0.001). As the severity of steatotic liver increased, measurements of ultrasound-guided attenuation parameter (UGAP) and uDFF also rose. Lipid parameters and liver enzymes were significant associated with UGAP and uDFF in boys, but not in girls. The uDFF values of the children with MASLD were positively correlated with weight (P<0.001), waist (P<0.001), body mass index (BMI) (P=0.001), fasting blood glucose (P=0.008), ALT (P<0.001) and AST (P<0.001).

CONCLUSIONS

Ultrasound-derived fat fraction technique has high diagnostic value in noninvasive quantitative assessment of hepatic steatosis in children with MASLD and reflects fat metabolism to some extent.

摘要

背景

代谢功能障碍相关脂肪性肝病(MASLD)在儿童和青少年中日益引起公众健康关注。本研究旨在评估超声衍生脂肪分数(uDFF)在量化MASLD患儿肝脏脂肪中的诊断价值,并探讨uDFF值与各种人体测量学和生化参数之间的相关性。

方法

本横断面研究纳入了230例经超声诊断为脂肪性肝病的儿童和38例健康对照。进行了体格检查、实验室检查和腹部超声检查。

结果

MASLD组包括168名男孩和62名女孩,平均年龄为9.8岁。男孩和女孩在腰围、丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平上存在显著差异。在230例MASLD患儿中,191例1级MASLD组患儿的平均uDFF值为11.52%,39例2级MASLD组患儿的平均uDFF值为19.10%,两组uDFF值比较差异有统计学意义(P<0.001)。随着脂肪性肝病严重程度的增加,超声引导下衰减参数(UGAP)和uDFF的测量值也升高。脂质参数和肝酶在男孩中与UGAP和uDFF显著相关,但在女孩中不相关。MASLD患儿的uDFF值与体重(P<0.001)、腰围(P<0.001)、体重指数(BMI)(P=0.001)、空腹血糖(P=0.008)、ALT(P<0.001)和AST(P<0.001)呈正相关。

结论

超声衍生脂肪分数技术在无创定量评估MASLD患儿肝脂肪变性方面具有较高的诊断价值,并在一定程度上反映脂肪代谢情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0196/12209668/19c0331a4d76/qims-15-06-5582-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0196/12209668/d405cff934d8/qims-15-06-5582-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0196/12209668/19c0331a4d76/qims-15-06-5582-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0196/12209668/d405cff934d8/qims-15-06-5582-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0196/12209668/19c0331a4d76/qims-15-06-5582-f2.jpg

相似文献

1
Assessment of hepatic steatosis in children with metabolic dysfunction-associated steatotic liver disease using ultrasound derived fat fraction: first large-scale clinical evaluation.利用超声衍生脂肪分数评估代谢功能障碍相关脂肪性肝病患儿的肝脂肪变性:首次大规模临床评估
Quant Imaging Med Surg. 2025 Jun 6;15(6):5582-5592. doi: 10.21037/qims-24-2393. Epub 2025 May 30.
2
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease.水飞蓟素用于患有代谢功能障碍相关脂肪性肝病的成年人。
Cochrane Database Syst Rev. 2025 Jun 24;6(6):CD015524. doi: 10.1002/14651858.CD015524.pub2.
3
The Significance of the Presence of Gilbert's Syndrome in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Retrospective Cohort Study.吉尔伯特综合征在代谢功能障碍相关脂肪性肝病(MASLD)患者中的意义:一项回顾性队列研究
Cureus. 2025 May 30;17(5):e85074. doi: 10.7759/cureus.85074. eCollection 2025 May.
4
Dietary lipophilic index and odds of metabolic dysfunction-associated steatotic liver disease (MASLD): A population-based study.饮食亲脂性指数与代谢功能障碍相关脂肪性肝病(MASLD)的患病几率:一项基于人群的研究。
Dig Liver Dis. 2025 Jul;57(7):1455-1464. doi: 10.1016/j.dld.2025.04.001. Epub 2025 May 13.
5
Aerobic-Resistance Training with Royal Jelly Supplementation Has a Synergistic Effect on Paraoxonase 1 Changes and Liver Function in Women with MASLD.补充蜂王浆的有氧抗阻训练对患有代谢功能障碍相关脂肪性肝病(MASLD)的女性的对氧磷酶1变化和肝功能具有协同作用。
Medicina (Kaunas). 2025 Feb 17;61(2):349. doi: 10.3390/medicina61020349.
6
Relationship between glucagon and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus.2型糖尿病患者中胰高血糖素与代谢功能障碍相关脂肪性肝病的关系。
World J Hepatol. 2025 Jun 27;17(6):104693. doi: 10.4254/wjh.v17.i6.104693.
7
Efficacy and safety of time-restricted eating in metabolic dysfunction-associated steatotic liver disease.限时进食在代谢功能障碍相关脂肪性肝病中的疗效与安全性
J Hepatol. 2025 Jun 19. doi: 10.1016/j.jhep.2025.06.005.
8
Dietary manganese intake is positively associated with metabolic dysfunction-associated steatotic liver disease: a multicohort study.膳食锰摄入量与代谢功能障碍相关脂肪性肝病呈正相关:一项多队列研究。
Eur J Nutr. 2025 May 26;64(5):188. doi: 10.1007/s00394-025-03708-8.
9
Linking gut permeability to liver steatosis: Noninvasive biomarker evaluation in MASLD patients - a prospective cross-sectional study.将肠道通透性与肝脂肪变性联系起来:非酒精性脂肪性肝病患者的非侵入性生物标志物评估——一项前瞻性横断面研究。
Medicine (Baltimore). 2025 May 23;104(21):e42476. doi: 10.1097/MD.0000000000042476.
10
Ultrasound hepatorenal index for the diagnosis of steatosis in patients with type 2 diabetes: a prospective validation study.超声肝肾指数用于诊断2型糖尿病患者肝脂肪变性:一项前瞻性验证研究。
Eur Radiol. 2025 Jun 25. doi: 10.1007/s00330-025-11774-z.

本文引用的文献

1
Performance of ATT and UDFF in the diagnosis of non-alcoholic fatty liver: An animal experiment.抗结核治疗(ATT)和超声衰减脂肪肝分数(UDFF)在非酒精性脂肪肝诊断中的性能:一项动物实验。
Heliyon. 2024 Mar 18;10(7):e27993. doi: 10.1016/j.heliyon.2024.e27993. eCollection 2024 Apr 15.
2
Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.应用超声弹性成像技术检测代谢相关脂肪性肝病高危人群肝脏脂肪分数的非侵入性评估。
Diabetes Metab Res Rev. 2024 Mar;40(3):e3787. doi: 10.1002/dmrr.3787.
3
Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease.
基于超声的脂肪分数在评估非酒精性脂肪性肝病肝脂肪变性中的跨平台可重复性。
Insights Imaging. 2024 Feb 14;15(1):46. doi: 10.1186/s13244-024-01611-0.
4
Real-time ultrasound-derived fat fraction in pediatric population: feasibility validation with MR-PDFF.实时超声衍生的小儿群体脂肪分数:MR-PDFF 的可行性验证。
Pediatr Radiol. 2023 Nov;53(12):2466-2475. doi: 10.1007/s00247-023-05752-0. Epub 2023 Sep 5.
5
Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content.超声衍生的脂肪分数用于检测肝脂肪变性和定量肝脏脂肪含量。
Radiol Med. 2023 Oct;128(10):1174-1180. doi: 10.1007/s11547-023-01693-8. Epub 2023 Aug 12.
6
Which obesity index is the most useful marker for predicting hepatic steatosis in children and adolescents with obesity? A cross-sectional study using quantitative magnetic resonance imaging.对于肥胖的儿童和青少年,哪种肥胖指数是预测肝脂肪变性最有用的指标?一项使用定量磁共振成像的横断面研究。
Obes Res Clin Pract. 2023 Jul-Aug;17(4):335-342. doi: 10.1016/j.orcp.2023.05.013. Epub 2023 Jun 17.
7
[A cross-sectional study on the prevalence rate and influencing factors of non-alcoholic fatty liver disease in overweight/obese children].超重/肥胖儿童非酒精性脂肪性肝病患病率及影响因素的横断面研究
Zhongguo Dang Dai Er Ke Za Zhi. 2023 May 15;25(5):448-456. doi: 10.7499/j.issn.1008-8830.2211018.
8
Ultrasound attenuation imaging: a reproducible alternative for the noninvasive quantitative assessment of hepatic steatosis in children.超声衰减成像:一种可重复的替代方法,用于无创定量评估儿童肝脂肪变性。
Pediatr Radiol. 2023 Jul;53(8):1618-1628. doi: 10.1007/s00247-023-05601-0. Epub 2023 Mar 4.
9
Liver Ultrasound Attenuation: An Ultrasound Attenuation Index for Liver Steatosis Assessment.肝脏超声衰减:一种用于评估肝脂肪变性的超声衰减指数。
Ultrasound Q. 2022 Jun 1;38(2):124-132. doi: 10.1097/RUQ.0000000000000605.
10
Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper.超声定量肝脏脂肪含量:WFUMB 立场文件。
Ultrasound Med Biol. 2021 Oct;47(10):2803-2820. doi: 10.1016/j.ultrasmedbio.2021.06.002. Epub 2021 Jul 18.